Ancora Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Ancora Advisors's BSX Position: Q2 2026 in Review
Ancora Advisors reduced its Boston Scientific (BSX) stake by 55% in Q2 2026, selling an estimated $243K and leaving 3,585 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #787.
Ancora Advisors first reported a position in BSX in Q3 2018 and has held it in 21 quarters since. The position peaked at $632K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Ancora Advisors held 3,585 shares of Boston Scientific worth $153K as of Q2 2026.
- Ancora Advisors sold 4,467 Boston Scientific shares in Q2 2026, an estimated $243K.
- Boston Scientific made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #787 holding.
- Ancora Advisors first reported a position in Boston Scientific in Q3 2018 and has held it in 21 quarters since.
- Ancora Advisors's Boston Scientific position peaked at $632K in Q4 2025.
- 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.